首页 > 最新文献

Technical Innovations and Patient Support in Radiation Oncology最新文献

英文 中文
AI based sentiment analysis of online discussions related to cervical brachytherapy 基于人工智能的宫颈近距离治疗相关在线讨论情绪分析
IF 2.8 Q1 Nursing Pub Date : 2025-09-02 DOI: 10.1016/j.tipsro.2025.100340
R. Kouzy , M.K. Rooney , E.E. Cha , S. Vinjamuri , H. Wu , Z.El Kouzi , O. Mohamad , T.T. Sims , C.R. Weil , N. Taku , L.L. Lin , A. Jhingran , P. Eifel , M. Joyner , L.E. Colbert , A.H. Klopp

Purpose/Objective(s)

Few studies have documented the experiences of patients receiving cervical brachytherapy. While evidence regarding quality of life issues in this population has emerged, traditional structured questionnaires often fail to capture the full range of patient perspectives. We hypothesized that analyzing unfiltered patient discussions from online forums would reveal unique insights into patient experiences, including previously unidentified emotional responses, concerns, and coping strategies. This study applied an artificial intelligence (AI) workflow to analyze cervical cancer and brachytherapy discussions from an online forum.

Materials/Methods

We extracted posts and comments from the subreddit r/cervicalcancer, focusing on discussions about brachytherapy between November 2020 and January 2024. We applied a processing pipeline to prepare the data for analysis. The content was analyzed using RoBERTa, a pre-trained deep learning model, to categorize sentiments as positive, negative, or neutral. We further evaluated posts using pre-defined keyword tagging to identify dominant topics within conversations based on recent literature.

Results

The analysis encompassed 898 unique posts and comments from an initial dataset of 1075 entries. Overall sentiments were categorized as 40.4% positive, 29.9% negative, and 29.7% neutral. Discussions related to “Bowel Domain” showed the highest proportion of negative sentiments (51.2%) among all topics. “Urinary Domain” (46.8%), “Pain” (43.4%), “Fatigue” (42.4%), and “Anesthesia” (41.4%) discussions also reflected predominantly negative sentiments. In contrast, “Recovery” and “Survivorship” discussions were predominantly positive. The sentiments on “Sex” and “Mental Health” related topics displayed a more balanced distribution between positive and negative perspectives.

Conclusion

Our study demonstrates the value of analyzing unstructured patient narratives from online forums related to cervical brachytherapy. We identified patterns of concerns that can inform clinical practice, particularly regarding patient education about bowel and urinary side effects. These findings can improve informed consent discussions and help clinicians better address patients’ significant concerns. Further work will focus on developing automated systems to bridge the gap between clinicians’ understanding and patients’ lived experiences.
目的/目的:很少有研究记录了接受宫颈近距离放疗的患者的经历。虽然关于这一人群生活质量问题的证据已经出现,但传统的结构化问卷调查往往无法捕捉到患者的全部观点。我们假设,分析来自在线论坛的未经过滤的患者讨论将揭示对患者体验的独特见解,包括以前未识别的情绪反应、担忧和应对策略。本研究应用人工智能(AI)工作流来分析在线论坛上关于宫颈癌和近距离治疗的讨论。材料/方法我们从reddit r/子宫颈癌版块中提取帖子和评论,重点关注2020年11月至2024年1月期间关于近距离放疗的讨论。我们应用了一个处理管道来准备用于分析的数据。使用RoBERTa(一种预先训练的深度学习模型)对内容进行分析,将情绪分为积极、消极或中性。我们进一步使用预定义的关键字标签来评估帖子,以确定基于最近文献的对话中的主导话题。结果分析包括来自1075个条目的初始数据集的898个独立帖子和评论。总体情绪为40.4%,29.9%为负面,29.7%为中性。在所有话题中,“肠域”的负面情绪比例最高(51.2%)。“泌尿系统”(46.8%)、“疼痛”(43.4%)、“疲劳”(42.4%)和“麻醉”(41.4%)的讨论也主要反映了负面情绪。相比之下,“康复”和“幸存者”的讨论主要是积极的。对“性”和“心理健康”相关话题的看法在积极和消极观点之间的分布更为平衡。结论:我们的研究证明了分析来自与颈椎近距离放疗相关的在线论坛的非结构化患者叙述的价值。我们确定了可以为临床实践提供信息的关注模式,特别是关于患者对肠道和泌尿系统副作用的教育。这些发现可以改善知情同意的讨论,并帮助临床医生更好地解决患者的重大问题。进一步的工作将集中在开发自动化系统,以弥合临床医生的理解和患者的生活经验之间的差距。
{"title":"AI based sentiment analysis of online discussions related to cervical brachytherapy","authors":"R. Kouzy ,&nbsp;M.K. Rooney ,&nbsp;E.E. Cha ,&nbsp;S. Vinjamuri ,&nbsp;H. Wu ,&nbsp;Z.El Kouzi ,&nbsp;O. Mohamad ,&nbsp;T.T. Sims ,&nbsp;C.R. Weil ,&nbsp;N. Taku ,&nbsp;L.L. Lin ,&nbsp;A. Jhingran ,&nbsp;P. Eifel ,&nbsp;M. Joyner ,&nbsp;L.E. Colbert ,&nbsp;A.H. Klopp","doi":"10.1016/j.tipsro.2025.100340","DOIUrl":"10.1016/j.tipsro.2025.100340","url":null,"abstract":"<div><h3>Purpose/Objective(s)</h3><div>Few studies have documented the experiences of patients receiving cervical brachytherapy. While evidence regarding quality of life issues in this population has emerged, traditional structured questionnaires often fail to capture the full range of patient perspectives. We hypothesized that analyzing unfiltered patient discussions from online forums would reveal unique insights into patient experiences, including previously unidentified emotional responses, concerns, and coping strategies. This study applied an artificial intelligence (AI) workflow to analyze cervical cancer and brachytherapy discussions from an online forum.</div></div><div><h3>Materials/Methods</h3><div>We extracted posts and comments from the subreddit r/cervicalcancer, focusing on discussions about brachytherapy between November 2020 and January 2024. We applied a processing pipeline to prepare the data for analysis. The content was analyzed using RoBERTa, a pre-trained deep learning model, to categorize sentiments as positive, negative, or neutral. We further evaluated posts using pre-defined keyword tagging to identify dominant topics within conversations based on recent literature.</div></div><div><h3>Results</h3><div>The analysis encompassed 898 unique posts and comments from an initial dataset of 1075 entries. Overall sentiments were categorized as 40.4% positive, 29.9% negative, and 29.7% neutral. Discussions related to “Bowel Domain” showed the highest proportion of negative sentiments (51.2%) among all topics. “Urinary Domain” (46.8%), “Pain” (43.4%), “Fatigue” (42.4%), and “Anesthesia” (41.4%) discussions also reflected predominantly negative sentiments. In contrast, “Recovery” and “Survivorship” discussions were predominantly positive. The sentiments on “Sex” and “Mental Health” related topics displayed a more balanced distribution between positive and negative perspectives.</div></div><div><h3>Conclusion</h3><div>Our study demonstrates the value of analyzing unstructured patient narratives from online forums related to cervical brachytherapy. We identified patterns of concerns that can inform clinical practice, particularly regarding patient education about bowel and urinary side effects. These findings can improve informed consent discussions and help clinicians better address patients’ significant concerns. Further work will focus on developing automated systems to bridge the gap between clinicians’ understanding and patients’ lived experiences.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"36 ","pages":"Article 100340"},"PeriodicalIF":2.8,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145047859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective review of patient factors impacting free-breathing respiratory motion magnitude for MR-guided radiotherapy 磁共振引导放射治疗中影响自由呼吸呼吸运动强度的患者因素的回顾性分析
IF 2.8 Q1 Nursing Pub Date : 2025-09-01 DOI: 10.1016/j.tipsro.2025.100339
Mairead Daly , Holly Egan , Ananya Choudhury , Ganesh Radhakrishna , Cynthia L. Eccles
Patient factors may influence motion management strategy selection for abdominal stereotactic ablative radiotherapy (SABR). This retrospective evaluation investigated the impact of body mass index (BMI), sex, and cirrhosis in 16 patients imaged with cine-magnetic resonance imaging (MRI) on a 1.5 T magnetic resonance linear accelerator (MR Linac). Male patients, those with cirrhosis, and higher BMI tended to exhibit greater motion magnitude, although this was not statistically significant, suggesting that these patients should be prioritised for motion management strategies. Further investigation in larger cohorts is warranted to confirm these trends and guide personalised motion management in abdominal radiotherapy.
患者因素可能影响腹部立体定向消融放疗(SABR)的运动管理策略选择。本回顾性评估研究了16例在1.5 T磁共振直线加速器(MR Linac)上进行电影磁共振成像(MRI)成像的患者的体重指数(BMI)、性别和肝硬化的影响。男性患者、肝硬化患者和高BMI患者倾向于表现出更大的运动幅度,尽管这在统计学上并不显著,这表明这些患者应该优先考虑运动管理策略。有必要在更大的队列中进行进一步的调查,以确认这些趋势,并指导腹部放疗的个性化运动管理。
{"title":"Retrospective review of patient factors impacting free-breathing respiratory motion magnitude for MR-guided radiotherapy","authors":"Mairead Daly ,&nbsp;Holly Egan ,&nbsp;Ananya Choudhury ,&nbsp;Ganesh Radhakrishna ,&nbsp;Cynthia L. Eccles","doi":"10.1016/j.tipsro.2025.100339","DOIUrl":"10.1016/j.tipsro.2025.100339","url":null,"abstract":"<div><div>Patient factors may influence motion management strategy selection for abdominal stereotactic ablative radiotherapy (SABR). This retrospective evaluation investigated the impact of body mass index (BMI), sex, and cirrhosis in 16 patients imaged with cine-magnetic resonance imaging (MRI) on a 1.5 T magnetic resonance linear accelerator (MR Linac). Male patients, those with cirrhosis, and higher BMI tended to exhibit greater motion magnitude, although this was not statistically significant, suggesting that these patients should be prioritised for motion management strategies. Further investigation in larger cohorts is warranted to confirm these trends and guide personalised motion management in abdominal radiotherapy.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100339"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144922017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to Correspondence by Kleebayoon and Wiwanitkit 答复Kleebayoon和Wiwanitkit的信件
IF 2.8 Q1 Nursing Pub Date : 2025-09-01 DOI: 10.1016/j.tipsro.2025.100342
Andreea C. Ciobanu , Virgil Sivoglo , Diana Maican , Ferenc Járai-Szabó , Zoltán Bálint
{"title":"Reply to Correspondence by Kleebayoon and Wiwanitkit","authors":"Andreea C. Ciobanu ,&nbsp;Virgil Sivoglo ,&nbsp;Diana Maican ,&nbsp;Ferenc Járai-Szabó ,&nbsp;Zoltán Bálint","doi":"10.1016/j.tipsro.2025.100342","DOIUrl":"10.1016/j.tipsro.2025.100342","url":null,"abstract":"","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100342"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145044368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence on “Custom-made, 3D-printed bolus cap for a case of scalp metastasis: A single-institution study” “一项针对头皮转移病例的定制3d打印丸帽:一项单机构研究”
IF 2.8 Q1 Nursing Pub Date : 2025-09-01 DOI: 10.1016/j.tipsro.2025.100341
Amnuay Kleebayoon , Viroj Wiwanitkit
{"title":"Correspondence on “Custom-made, 3D-printed bolus cap for a case of scalp metastasis: A single-institution study”","authors":"Amnuay Kleebayoon ,&nbsp;Viroj Wiwanitkit","doi":"10.1016/j.tipsro.2025.100341","DOIUrl":"10.1016/j.tipsro.2025.100341","url":null,"abstract":"","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100341"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144931561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Standard operating procedure (SOP) for immobilisation, scanning, verification and treatment of breast cancer patients undergoing proton beam therapy 乳癌病人接受质子束治疗的固定、扫描、验证及治疗的标准操作程序(SOP)
IF 2.8 Q1 Nursing Pub Date : 2025-09-01 DOI: 10.1016/j.tipsro.2025.100331
Kathryn Osborn , Jaymisha Davda , Rita Simoes , Michael O’Connor , Olivia Willis , Sarah Gulliford , Syed Ali Moinuddin , Turmi Patel , Sarah Petty , Mahbubl Ahmed , Thomas Richards , Sairanne Wickers
The use of proton beam therapy (PBT) for breast cancer is not currently included for standard consideration on the NHS England indication list. However, there are occasions where the use of PBT may be approved in the United Kingdom (UK), such as breast sarcoma, as part of a clinical trial or due to a photon plan meeting a threshold for significant risk of acute and late toxicities (e.g. pre-existing co-morbidities). Due to the beam characteristics, the use of PBT for breast treatment poses challenges in terms of the immobilisation, pre-treatment scanning, treatment verification and delivery. This standard operating procedure (SOP) details strategies to mitigate these that were developed as part of the implementation of breast PBT at our institution. This SOP will support existing and new PBT services when treating this patient cohort, by providing a detailed step-by-step guide to improve consistency and efficiency in the management of breast PBT.
使用质子束疗法(PBT)治疗乳腺癌目前不包括在英国国民保健服务指征清单的标准考虑。然而,在某些情况下,PBT的使用可能会在英国获得批准,如乳腺肉瘤,作为临床试验的一部分,或由于光子计划达到急性和晚期毒性显著风险的阈值(例如,预先存在的合共病)。由于光束的特性,PBT在乳房治疗中的应用在固定、治疗前扫描、治疗验证和输送方面提出了挑战。本标准操作程序(SOP)详细介绍了缓解这些问题的策略,这些策略是作为我们机构实施乳房PBT的一部分而制定的。本SOP将通过提供详细的分步指南来提高乳腺PBT管理的一致性和效率,从而支持现有和新的PBT服务在治疗该患者队列时。
{"title":"Standard operating procedure (SOP) for immobilisation, scanning, verification and treatment of breast cancer patients undergoing proton beam therapy","authors":"Kathryn Osborn ,&nbsp;Jaymisha Davda ,&nbsp;Rita Simoes ,&nbsp;Michael O’Connor ,&nbsp;Olivia Willis ,&nbsp;Sarah Gulliford ,&nbsp;Syed Ali Moinuddin ,&nbsp;Turmi Patel ,&nbsp;Sarah Petty ,&nbsp;Mahbubl Ahmed ,&nbsp;Thomas Richards ,&nbsp;Sairanne Wickers","doi":"10.1016/j.tipsro.2025.100331","DOIUrl":"10.1016/j.tipsro.2025.100331","url":null,"abstract":"<div><div>The use of proton beam therapy (PBT) for breast cancer is not currently included for standard consideration on the NHS England indication list. However, there are occasions where the use of PBT may be approved in the United Kingdom (UK), such as breast sarcoma, as part of a clinical trial or due to a photon plan meeting a threshold for significant risk of acute and late toxicities (e.g. pre-existing co-morbidities). Due to the beam characteristics, the use of PBT for breast treatment poses challenges in terms of the immobilisation, pre-treatment scanning, treatment verification and delivery. This standard operating procedure (SOP) details strategies to mitigate these that were developed as part of the implementation of breast PBT at our institution. This SOP will support existing and new PBT services when treating this patient cohort, by providing a detailed step-by-step guide to improve consistency and efficiency in the management of breast PBT.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100331"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144931559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A standardised workflow to manage the complexity of reirradiation and radiotherapy retreatments in clinical practice 在临床实践中管理再照射和放疗再治疗复杂性的标准化工作流程
IF 2.8 Q1 Nursing Pub Date : 2025-09-01 DOI: 10.1016/j.tipsro.2025.100336
Madalyne Day, Jonas Willmann, Panagiotis Balermpas, Riccardo Dal Bello, Anja Joye, Laura Motisi, Jens von der Grün, Crystal Sulaiman, Lotte Wilke, Nazanin Rahnama, Matthias Guckenberger, Stephanie Tanadini-Lang, Nicolaus Andratschke
As cancer patients survive longer, the number of radiotherapy retreatments is steadily increasing [1], requiring laborious review of previous treatments, decisions regarding image registration, dose accumulation and assessment of such composite dose distributions. This work presents the development, and implementation of a standardised dedicated workflow for reirradiation (reRT) and radiotherapy retreatment based on the EORTC/ESTRO consensus on reRT.
随着癌症患者生存时间的延长,放疗再治疗的次数也在稳步增加,这就需要对以往的治疗进行繁琐的回顾、对图像配准的决定、剂量积累以及对这种复合剂量分布的评估。这项工作提出了基于EORTC/ESTRO关于再照射(ert)和放疗再治疗共识的标准化专用工作流程的开发和实施。
{"title":"A standardised workflow to manage the complexity of reirradiation and radiotherapy retreatments in clinical practice","authors":"Madalyne Day,&nbsp;Jonas Willmann,&nbsp;Panagiotis Balermpas,&nbsp;Riccardo Dal Bello,&nbsp;Anja Joye,&nbsp;Laura Motisi,&nbsp;Jens von der Grün,&nbsp;Crystal Sulaiman,&nbsp;Lotte Wilke,&nbsp;Nazanin Rahnama,&nbsp;Matthias Guckenberger,&nbsp;Stephanie Tanadini-Lang,&nbsp;Nicolaus Andratschke","doi":"10.1016/j.tipsro.2025.100336","DOIUrl":"10.1016/j.tipsro.2025.100336","url":null,"abstract":"<div><div>As cancer patients survive longer, the number of radiotherapy retreatments is steadily increasing [<span><span>1</span></span>], requiring laborious review of previous treatments, decisions regarding image registration, dose accumulation and assessment of such composite dose distributions. This work presents the development, and implementation of a standardised dedicated workflow for reirradiation (reRT) and radiotherapy retreatment based on the EORTC/ESTRO consensus on reRT.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100336"},"PeriodicalIF":2.8,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144931560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of tattoo reliability in breast cancer re-irradiation 纹身在乳腺癌再照射中的可靠性评价
IF 2.8 Q1 Nursing Pub Date : 2025-08-22 DOI: 10.1016/j.tipsro.2025.100338
Grace Lee , Michael Velec , Hedi Mohseni , Tara Rosewall , Yat Tsang , Jennifer Croke

Background

Tattoos help guide field placement in breast re-irradiation. This study evaluates the stability of medial tattoos in patients with prior breast radiotherapy (RT) to determine their reliability as surface markers.

Materials and methods

We retrospectively identified patients who had breast/chest wall re-irradiation between January 2022 and December 2023 (RT2) and prior breast RT (RT1) at our institution. Planning CTs for both RT courses were registered using rigid image registration. The medial tattoo, sternum, and internal perforating branches of the internal thoracic vessels were contoured on both CT1 and CT2, and POIs were placed at the respective centers to assess shifts and 3D distances reported as target registration errors (TRE).

Results

Eighteen patients were included, average sternum 3D TRE was 0.8 mm(SD0.8), within CT voxel thickness. The average medial tattoo 3D TRE was 9.2 mm(SD5.4). Significantly greater 3D TRE was observed in patients whose arm positions varied between scans (Same: 4.7 mm vs Different: 10.9 mm, p = 0.002). The largest 3D TRE was 22.1 mm, observed in a patient who had a mastectomy before RT2. The average vessels 3D TRE was 4.1 mm (SD2.3) and impacted by arm position (Different = 4.4 mm vs Same = 2.9 mm, p = 0.009).

Conclusion

Relying solely on previous medial tattoos as indicators of the previous RT field border can be inaccurate due to arm positioning and surgical procedure changes that impact surface anatomy over time. Reproducing the patient’s original setup and arm positioning is essential to reducing registration errors in breast re-irradiation. If varying arm positions are unavoidable, internal thoracic perforator vessels may provide more robust registration.
背景纹身有助于指导乳房再照射的部位放置。本研究评估了既往乳房放疗(RT)患者内侧纹身的稳定性,以确定其作为表面标记物的可靠性。材料和方法回顾性研究了2022年1月至2023年12月期间在我院接受过乳房/胸壁再照射(RT2)和既往乳房放疗(RT1)的患者。两个RT课程的计划ct使用严格的图像配准进行注册。在CT1和CT2上勾画内侧纹身、胸骨和胸腔内血管的内部穿孔分支,并将poi放置在各自的中心,以评估移位和3D距离,报告为目标配准误差(TRE)。结果本组患者18例,胸骨三维三维立体扫描平均为0.8 mm(SD0.8),在CT体素厚度范围内。平均内侧纹身3D TRE为9.2 mm(SD5.4)。在两次扫描之间手臂位置不同的患者中,观察到明显更大的3D TRE(相同:4.7 mm vs不同:10.9 mm, p = 0.002)。在RT2前进行乳房切除术的患者中观察到最大的3D TRE为22.1 mm。血管三维TRE平均为4.1 mm (SD2.3),受臂位影响(差异= 4.4 mm vs相同= 2.9 mm, p = 0.009)。结论:由于手臂定位和手术方式的改变会随着时间的推移影响体表解剖结构,单纯依靠以前的内侧纹身作为以前RT野界的指标可能不准确。再现患者的原始设置和手臂的位置是必要的,以减少在乳房再照射登记错误。如果改变手臂位置是不可避免的,胸腔内穿支血管可以提供更强健的定位。
{"title":"Evaluation of tattoo reliability in breast cancer re-irradiation","authors":"Grace Lee ,&nbsp;Michael Velec ,&nbsp;Hedi Mohseni ,&nbsp;Tara Rosewall ,&nbsp;Yat Tsang ,&nbsp;Jennifer Croke","doi":"10.1016/j.tipsro.2025.100338","DOIUrl":"10.1016/j.tipsro.2025.100338","url":null,"abstract":"<div><h3>Background</h3><div>Tattoos help guide field placement in breast re-irradiation. This study evaluates the stability of medial tattoos in patients with prior breast radiotherapy (RT) to determine their reliability as surface markers.</div></div><div><h3>Materials and methods</h3><div>We retrospectively identified patients who had breast/chest wall re-irradiation between January 2022 and December 2023 (RT<sub>2</sub>) and prior breast RT (RT<sub>1</sub>) at our institution. Planning CTs for both RT courses were registered using rigid image registration. The medial tattoo, sternum, and internal perforating branches of the internal thoracic vessels were contoured on both CT<sub>1</sub> and CT<sub>2</sub>, and POIs were placed at the respective centers to assess shifts and 3D distances reported as target registration errors (TRE).</div></div><div><h3>Results</h3><div>Eighteen patients were included, average sternum 3D TRE was 0.8 mm(SD0.8), within CT voxel thickness. The average medial tattoo 3D TRE was 9.2 mm(SD5.4). Significantly greater 3D TRE was observed in patients whose arm positions varied between scans (Same: 4.7 mm vs Different: 10.9 mm, p = 0.002). The largest 3D TRE was 22.1 mm, observed in a patient who had a mastectomy before RT<sub>2</sub>. The average vessels 3D TRE was 4.1 mm (SD2.3) and impacted by arm position (Different = 4.4 mm vs Same = 2.9 mm, p = 0.009).</div></div><div><h3>Conclusion</h3><div>Relying solely on previous medial tattoos as indicators of the previous RT field border can be inaccurate due to arm positioning and surgical procedure changes that impact surface anatomy over time. Reproducing the patient’s original setup and arm positioning is essential to reducing registration errors in breast re-irradiation. If varying arm positions are unavoidable, internal thoracic perforator vessels may provide more robust registration.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100338"},"PeriodicalIF":2.8,"publicationDate":"2025-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144903108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical validation of using a commercial synthetic-computed tomography solution for brain MRI-only radiotherapy treatment planning 使用商用合成计算机断层扫描解决方案进行脑核磁共振放射治疗计划的临床验证
IF 2.8 Q1 Nursing Pub Date : 2025-08-20 DOI: 10.1016/j.tipsro.2025.100328
Lamyaa Aljaafari , Richard Speight , David L. Buckley , David Bird , Bashar Al-Qaisieh

Background and purpose

MRI-only radiotherapy treatment planning (RTP) relies on synthetic-CT (sCT) images for dose calculation. This study evaluates the clinical feasibility of using a commercial sCT solution in brain RTP, MRCAT Brain, focusing on dosimetric accuracy and patient setup verification.

Method and materials

For dosimetric evaluation, 93 patients with brain cancer who were treated with volumetric modulated arc therapy (VMAT) using a CT/MRI fusion workflow were included. sCT images were generated using MRCAT Brain. The sCT images were rigidly co-registered to the CT images. The clinical plan produced on the CT was recalculated on the sCT. Dosimetric accuracy was assessed by comparing dose differences in dose volume histogram (DVH) statistics for the planning target volume (PTV) and organs at risk (OARs).
For patient setup verification, 70 patients were included, and total of 572 cone beam CT (CBCT) registrations were performed with sCT and CT as reference images. The sCT matching accuracy was validated by comparing the translational and rotational differences between sCT-CBCT and CT-CBCT registrations.

Results

The PTV mean dose difference between CT and sCT were 0.3 %, 0.4 %, and 0.2 % for D50%, D2%, and D98%, respectively. The OAR mean dose differences were less than 0.3 % for all OARs. 4 of 93 patients (4.3 %) showed gross dosimetric errors of greater than ± 2 %. 3/4 were caused by sCT error. For positioning verification, all results were between ± 1 mm and ± 1°.

Conclusion

This study demonstrates the clinical feasibility of the MRCAT solution for brain MRI-only RTP, with dosimetric differences being clinically acceptable, along with submillimetre and sub-degree accuracy in patient setup verification.
背景与目的磁共振放射治疗计划(RTP)依赖于合成ct (sCT)图像进行剂量计算。本研究评估了商用sCT溶液在脑RTP、MRCAT脑中应用的临床可行性,重点关注剂量学准确性和患者设置验证。方法和材料为进行剂量学评估,纳入了93例采用CT/MRI融合工作流程进行体积调制电弧治疗(VMAT)的脑癌患者。sCT图像生成使用MRCAT脑。sCT图像与CT图像严格共配准。CT上生成的临床计划在sCT上重新计算。通过比较计划靶体积(PTV)和危险器官(OARs)的剂量体积直方图(DVH)统计数据的剂量差异来评估剂量学的准确性。为了验证患者设置,纳入了70例患者,并以sCT和CT作为参考图像进行了总共572例锥形束CT (CBCT)配准。通过比较sCT- cbct和CT-CBCT配准之间的平移和旋转差异来验证sCT匹配的准确性。结果D50%、D2%和D98%时,CT与sCT的PTV平均剂量差分别为0.3%、0.4%和0.2%。所有桨的平均剂量差异小于0.3%。93例患者中4例(4.3%)的总剂量学误差大于±2%。3/4是由sCT错误引起的。定位验证结果均在±1 mm ~±1°之间。本研究证明了MRCAT溶液用于脑mri RTP的临床可行性,剂量学差异在临床上是可接受的,并且在患者设置验证中具有亚毫米和亚度的准确性。
{"title":"Clinical validation of using a commercial synthetic-computed tomography solution for brain MRI-only radiotherapy treatment planning","authors":"Lamyaa Aljaafari ,&nbsp;Richard Speight ,&nbsp;David L. Buckley ,&nbsp;David Bird ,&nbsp;Bashar Al-Qaisieh","doi":"10.1016/j.tipsro.2025.100328","DOIUrl":"10.1016/j.tipsro.2025.100328","url":null,"abstract":"<div><h3>Background and purpose</h3><div>MRI-only radiotherapy treatment planning (RTP) relies on synthetic-CT (sCT) images for dose calculation. This study evaluates the clinical feasibility of using a commercial sCT solution in brain RTP, MRCAT Brain, focusing on dosimetric accuracy and patient setup verification.</div></div><div><h3>Method and materials</h3><div>For dosimetric evaluation, 93 patients with brain cancer who were treated with volumetric modulated arc therapy (VMAT) using a CT/MRI fusion workflow were included. sCT images were generated using MRCAT Brain. The sCT images were rigidly co-registered to the CT images. The clinical plan produced on the CT was recalculated on the sCT. Dosimetric accuracy was assessed by comparing dose differences in dose volume histogram (DVH) statistics for the planning target volume (PTV) and organs at risk (OARs).</div><div>For patient setup verification, 70 patients were included, and total of 572 cone beam CT (CBCT) registrations were performed with sCT and CT as reference images. The sCT matching accuracy was validated by comparing the translational and rotational differences between sCT-CBCT and CT-CBCT registrations.</div></div><div><h3>Results</h3><div>The PTV mean dose difference between CT and sCT were 0.3 %, 0.4 %, and 0.2 % for D50%, D2%, and D98%, respectively. The OAR mean dose differences were less than 0.3 % for all OARs. 4 of 93 patients (4.3 %) showed gross dosimetric errors of greater than ± 2 %. 3/4 were caused by sCT error. For positioning verification, all results were between ± 1 mm and ± 1°.</div></div><div><h3>Conclusion</h3><div>This study demonstrates the clinical feasibility of the MRCAT solution for brain MRI-only RTP, with dosimetric differences being clinically acceptable, along with submillimetre and sub-degree accuracy in patient setup verification.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100328"},"PeriodicalIF":2.8,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144888785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024 再照射:评价肺癌治疗的发生和类型- 2024
IF 2.8 Q1 Nursing Pub Date : 2025-08-20 DOI: 10.1016/j.tipsro.2025.100337
Catherine Laferlita , Yiota Nicolaou , Katrina Woodford , Nicholas Hardcastle , Susan Harden , Kenton Thompson
With advancements in oncology practice, patients are living longer and returning for repeat courses of radiotherapy. Reirradiation (ReRT) is becoming a viable treatment option for patients. This single-institution, retrospective audit evaluates the number of patients with primary lung cancers who underwent radical retreatment to the thorax in 2024 and categorises them according to the European Society for Radiotherapy and Oncology (ESTRO) and European Organisation for Research and Treatment of Cancer (EORTC) consensus definition. Of the 511 patients with primary lung cancer in our institution who returned for further radiotherapy in 2024, 42 received radical retreatment to the thorax. Inconsistencies were seen in documentation across patient information platforms in relation to cumulative dose assessment and minimal documentation of radiobiological considerations such as equivalent dose in 2 Gy fraction (EQD2) were discovered. As a result of this study, recommendations were made to improve current practice.
随着肿瘤学实践的进步,患者的寿命延长,并返回重复疗程的放疗。再放射治疗(ret)正在成为一种可行的治疗选择。这项单机构回顾性审计评估了2024年接受根治性胸部再治疗的原发性肺癌患者的数量,并根据欧洲放射与肿瘤学会(ESTRO)和欧洲癌症研究与治疗组织(EORTC)的共识定义对其进行了分类。本院511例原发性肺癌患者于2024年复诊接受进一步放疗,其中42例接受胸部根治性再治疗。在患者信息平台的文件中发现了与累积剂量评估有关的不一致,并发现了最小的放射生物学考虑因素文件,如2 Gy分数的等效剂量(EQD2)。根据这项研究,提出了改进现行做法的建议。
{"title":"Reirradiation: Evaluation of the occurrence and type in cancer treatment for lung – 2024","authors":"Catherine Laferlita ,&nbsp;Yiota Nicolaou ,&nbsp;Katrina Woodford ,&nbsp;Nicholas Hardcastle ,&nbsp;Susan Harden ,&nbsp;Kenton Thompson","doi":"10.1016/j.tipsro.2025.100337","DOIUrl":"10.1016/j.tipsro.2025.100337","url":null,"abstract":"<div><div>With advancements in oncology practice, patients are living longer and returning for repeat courses of radiotherapy. Reirradiation (ReRT) is becoming a viable treatment option for patients. This single-institution, retrospective audit evaluates the number of patients with primary lung cancers who underwent radical retreatment to the thorax in 2024 and categorises them according to the European Society for Radiotherapy and Oncology (ESTRO) and European Organisation for Research and Treatment of Cancer (EORTC) consensus definition. Of the 511 patients with primary lung cancer in our institution who returned for further radiotherapy in 2024, 42 received radical retreatment to the thorax. Inconsistencies were seen in documentation across patient information platforms in relation to cumulative dose assessment and minimal documentation of radiobiological considerations such as equivalent dose in 2 Gy fraction (EQD2) were discovered. As a result of this study, recommendations were made to improve current practice.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100337"},"PeriodicalIF":2.8,"publicationDate":"2025-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144885680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation therapist (RTT) perspectives on developing image-guided radiotherapy (IGRT) protocols for reirradiation 放射治疗师(RTT)对发展图像引导放射治疗(IGRT)再照射方案的看法
IF 2.8 Q1 Nursing Pub Date : 2025-08-14 DOI: 10.1016/j.tipsro.2025.100335
Aileen Duffton , Lynsey Devlin , Aoife Williamson , Derek Grose , Eilidh Tolmie , Linda MacLaren , Sharon McFadden , Rebecca Muirhead

Introduction

Prospective studies on reirradiation are limited, with most available data being retrospective, resulting in challenges in standardising protocols, interpreting outcomes, and facilitating informed patient decisions. Advanced radiotherapy planning and delivery have increased treatment possibilities for complex cases, including reirradiation. However, considerable gaps and variability in reirradiation image-guided radiotherapy (IGRT) and treatment delivery exist. The aim of this work was to identify ways to optimise reirradiation IGRT protocols based on RTT feedback.

Methods

A quantitative and qualitative service improvement approach was selected, using a plan, do, check approach. RTT participants working in a single RT centre participated in focus group/nominal group technique sessions. Sessions were used to generate themes, challenges and solutions, which were then scored using Likert scale scoring criteria by all participants.

Results

Eleven IGRT team members each with > 6 years experience participated in the sessions, (4 senior specialist clinical RTT, 2 team leader specialist RTT, 2 IGRT specialist RTT, 1 consultant RTT and 2 research RTT). Eight themes, 19 challenges and 35 solutions were identified. These included communication challenges and multi-professional team (MPT) involvement, RTT role and development, clinical information and treatment intent, standards and guidelines, individualised approach, technical planning considerations, imaging and verification techniques, and anatomical site-specific considerations.

Conclusion

The themes identified provide valuable insights that will inform future IGRT processes and inform future research collaborations on an international level, working towards improving reirradiation treatment for patients who would benefit. There are many opportunities for the RTT within the MPT, and advanced practice (AP) can provide the framework required to develop this for the benefit of patients.
关于再照射的前瞻性研究是有限的,大多数可用的数据是回顾性的,这导致了标准化方案、解释结果和促进知情患者决策的挑战。先进的放疗计划和交付增加了复杂病例的治疗可能性,包括再照射。然而,在再照射图像引导放疗(IGRT)和治疗递送方面存在相当大的差距和可变性。这项工作的目的是确定基于RTT反馈优化再照射IGRT方案的方法。方法采用计划、执行、检查的方法,采用定量和定性相结合的服务改进方法。在单一康复中心工作的康复治疗参与者参加了焦点小组/名义小组技术会议。会议被用来产生主题、挑战和解决方案,然后由所有参与者使用李克特量表评分标准进行评分。结果参加会议的IGRT团队成员均为6年以上,其中资深专家临床RTT 4人,组长专家RTT 2人,IGRT专家RTT 2人,顾问RTT 1人,研究RTT 2人。确定了8个主题、19个挑战和35个解决办法。这些挑战包括沟通挑战和多专业团队(MPT)参与、RTT的角色和发展、临床信息和治疗意图、标准和指南、个性化方法、技术规划考虑、成像和验证技术以及解剖部位特定考虑。确定的主题提供了有价值的见解,将为未来的IGRT过程提供信息,并为未来国际层面的研究合作提供信息,致力于改善患者的再照射治疗,使其受益。在MPT中,RTT有很多机会,而高级实践(AP)可以提供为患者利益开发RTT所需的框架。
{"title":"Radiation therapist (RTT) perspectives on developing image-guided radiotherapy (IGRT) protocols for reirradiation","authors":"Aileen Duffton ,&nbsp;Lynsey Devlin ,&nbsp;Aoife Williamson ,&nbsp;Derek Grose ,&nbsp;Eilidh Tolmie ,&nbsp;Linda MacLaren ,&nbsp;Sharon McFadden ,&nbsp;Rebecca Muirhead","doi":"10.1016/j.tipsro.2025.100335","DOIUrl":"10.1016/j.tipsro.2025.100335","url":null,"abstract":"<div><h3>Introduction</h3><div>Prospective studies on reirradiation are limited, with most available data being retrospective, resulting in challenges in standardising protocols, interpreting outcomes, and facilitating informed patient decisions. Advanced radiotherapy planning and delivery have increased treatment possibilities for complex cases, including reirradiation. However, considerable gaps and variability in reirradiation image-guided radiotherapy (IGRT) and treatment delivery exist. The aim of this work was to identify ways to optimise reirradiation IGRT protocols based on RTT feedback.</div></div><div><h3>Methods</h3><div>A quantitative and qualitative service improvement approach was selected, using a plan, do, check approach. RTT participants working in a single RT centre participated in focus group/nominal group technique sessions. Sessions were used to generate themes, challenges and solutions, which were then scored using Likert scale scoring criteria by all participants.</div></div><div><h3>Results</h3><div>Eleven IGRT team members each with &gt; 6 years experience participated in the sessions, (4 senior specialist clinical RTT, 2 team leader specialist RTT, 2 IGRT specialist RTT, 1 consultant RTT and 2 research RTT). Eight themes, 19 challenges and 35 solutions were identified. These included communication challenges and multi-professional team (MPT) involvement, RTT role and development, clinical information and treatment intent, standards and guidelines, individualised approach, technical planning considerations, imaging and verification techniques, and anatomical site-specific considerations.</div></div><div><h3>Conclusion</h3><div>The themes identified provide valuable insights that will inform future IGRT processes and inform future research collaborations on an international level, working towards improving reirradiation treatment for patients who would benefit. There are many opportunities for the RTT within the MPT, and advanced practice (AP) can provide the framework required to develop this for the benefit of patients.</div></div>","PeriodicalId":36328,"journal":{"name":"Technical Innovations and Patient Support in Radiation Oncology","volume":"35 ","pages":"Article 100335"},"PeriodicalIF":2.8,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144893564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Technical Innovations and Patient Support in Radiation Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1